Broad takes RNA CRISPR into viral infections
Cas13 continues to prove its worth as the latest Broad CRISPR study points to antiviral applications
The latest CRISPR study from the Broad Institute takes gene editing into infections caused by RNA viruses, using Cas13 -- which is proving to be one of the most versatile of the CRISPR-Cas enzyme family.
In a paper published in Molecular Cell on Thursday, a Broad Institute of MIT and Harvard team led by Pardis Sabeti showed that CRISPR-Cas13 can kill RNA viruses in infected cells.
Sabeti is an institute